Chi Mei Medical Hospital
Chi Mei Medical Hospital
Explore linked clinical trials.10 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Comparisons of Treatment Responses of Early Syphilis to Benzathine Penicillin G With or Without Doxycycline | Bacterial Infections and Mycoses, Genital Diseases, Infections, Treponema infectious disease, Urogenital Diseases, bacterial infectious disease, bacterial sexually transmitted disease, gram-negative bacterial infections, infectious disease, sexually transmitted disease, spirochaetales infections, syphilis | Recruiting | Not applicable | 2026-08-06 | NCT06069141 | |
| IVUS Guidance in BTK Interventions | Arterial Occlusive Diseases, Chronic Disease, Chronic Limb-Threatening Ischemia, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, ischemic disease, peripheral arterial disease, peripheral vascular disease, vascular disorder | Not yet recruiting | Not applicable | 2026-07-28 | NCT07731997 | |
| Colchicine in Chronic Limb-Threatening Ischemia | Arterial Occlusive Diseases, Chronic Disease, Chronic Limb-Threatening Ischemia, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, ischemic disease, peripheral arterial disease, peripheral vascular disease, vascular disorder | Recruiting | Phase 3 | 2026-07-14 | NCT07536373 | |
| Phase Ib/IIa Open-label Study, to Evaluate Safety, Tolerability, and Antitumor Activity of HCB101 in Combination With Multiple Agents in Subjects With Advanced Gastric or Gastro-esophageal (GEJ) Adenocarcinoma | GC/GEJC | Not yet recruiting | Phase 1 / Phase 2 | 2026-07-02 | NCT07680569 | |
| Home-based Outpatient Multicenter Evaluation Using Electrocardiogram (HOME-ECG) | cardiovascular disorder, heart disorder, heart failure | Recruiting | Not stated | 2026-03-25 | NCT07488052 | |
| Taiwan Post-Stroke Disability Study | Arterial Occlusive Diseases, Leukoencephalopathies, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, depressive disorder, epilepsy, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, psychiatric disorder, stroke disorder, vascular dementia, vascular disorder | Recruiting | Not stated | 2025-05-13 | NCT06772194 | |
| Neoadjuvant Tislelizumab, Gemcitabine, Cisplatin and S-1 for Resectable High-risk Cholangiocarcinoma | Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, biliary tract disorder, carcinoma, cholangiocarcinoma, epithelial neoplasm, neoplasm | Not yet recruiting | Phase 2 | 2025-03-30 | NCT06903273 | |
| Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines | Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic hepatitis B virus infection, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 4 | 2024-12-17 | NCT03753074 | |
| TAF to Prevent HBV Reactivation in Cancer Patients | Hepatitis B Reactivation | Active, not recruiting | Phase 4 | 2024-11-12 | NCT04619082 | |
| Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Active, not recruiting | Phase 4 | 2024-11-12 | NCT03024684 |